EGFR and cervical carcinoma: In cervical cancer, H3K27 acetylation-activated EGFR-AS1 interacts with miR-2355-5p and activates the ACTN4-mediated WNT pathway to promote the proliferation, migration, and invasion of SiHa and CaSki cells (42).